InvestorsHub Logo
Followers 5
Posts 654
Boards Moderated 1
Alias Born 10/11/2014

Re: None

Sunday, 02/05/2017 8:36:03 PM

Sunday, February 05, 2017 8:36:03 PM

Post# of 1371
This is a massive operation !! Look at Facility in Europe below.

Major LP's will want to partner with us or just take us out ...They want the European market !

Facility video 1

Facility video 2

Picture

VIN NUMBERS: audited annual sales in excess of CAD $14,000,000 and adjusted EBITDA of over $2,000,000

vs

Canopy Growth Numbers


Do the math people...VNNYF is a target for the big boyz, who will act 1st...?

Access to an extensive catalogue of over 2000 hemp and cannabis strains

I don't think people understand the value of those strains with IP (Intellectual Property) But the big players will....

VNNYF (MJ BIOPHARMA) PLAN:

* Expand rapidly into the hemp, cannabis and cannabinoid (CBD) sectors across Europe.

* Utilize our first mover advantage to take a leading market position in multiple countries

* "Given the current marketplace dynamics, existing customer base and technology we now have access to; we plan to immediately roll out several new hemp and CBD initiatives.

* "Our goal has always been to control every step of the production process from genetics, right through to extraction, ensuring only the highest quality extracts are used in the formulation of our strips, time release capsules and other products currently under development for the medical and recreational cannabis space,"

* The Company will aim to work with large growers and provide access for them to a comprehensive catalogue of cannabis strains.

* MJ Biopharma's expertise lies in its extracts and custom formulations. The company will also aim to in- license and joint venture on best in class technologies and products for both the medicinal and recreational markets - domestically and internationally.


About MJ Biopharma


MJ Biopharma is a cannabis technology company with a team of highly experienced business and medical professionals, biochemists and researchers. The company is currently focused on the following areas of interest:

Manufacturing breath strips;
Time release capsules;
Extract oils;
Food products and infused juices, teas, coffee and extract drinks;
Pharmaceutical grade delivery systems;

MJ BIOPHARMA